Published: 2020-06-24

Association of vitamin D deficiency and bone mass with liver and heart iron overload in transfusion dependent thalassemia

Anjali Verma, Alok Khanna, Babita Jangra, Sanjiv Nanda, Surender Verma


Background: Transfusion dependent thalassemia patients are reported to have Vitamin D insufficiency/deficiency in many countries. Vitamin D hydroxylation occurs in the liver; whether liver iron overload interferes with this step has not been addressed till date. This study helps to establish an association between liver iron concentration (LIC) and heart iron concentration (MIC) with vitamin D levels and Bone Mass Density in these patients.

Methods: A cross sectional study was done by including transfusion dependent Thalassemia patients (TM) if they had an assessment of Liver and cardiac iron done by T2*MRI and bone mineral density by DEXA. Clinical data regarding age, gender, type of iron chelation therapy and laboratory data of S. ferritin and Vitamin D was collected. Data was assessed using appropriate statistical methods.

Results: Among 40 TM patients were taken and mean age was 17.6 years. Vitamin D deficiency was identified in 26(65%). 20 out of them had an LIC>7mg/g DW and 6 had MIC>1.65mg/g DW. There was a significant association between LIC>7mg/g and vitamin D level<20 ng/ml and a significant inverse correlation between LIC and vitamin D, suggesting that liver iron overload may indeed affect vitamin D metabolism. Osteopenia was present in 32.5% and osteoporosis was present in 27.5 % of all TM patients. Reduced Bone Mass Density was also found to be linked with iron over load.

Conclusions: Regular monitoring of vitamin D levels and supplementation is required in patients with severe liver and heart iron load. More studies are needed to confirm these results.


Chelation, Osteopenia, Vitamin D insufficiency

Full Text:



Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010;21;5:11.

Wonke B, Jensen C, Hanslip JJ, Prescott E, Lalloz M, Layton M, et al. Genetic and acquired predisposing factors and treatment of osteoporosis in thalassaemia major. J Pediatr Endocrinol Metabolism. JPEM. 1998;11:795-801.

Wonke B. Bone disease in β-thalassaemia major. Br J Haematol. 1998;103:897-901.

Mahachoklertwattana P, Sirikulchayanonta V, Chuansumrit A, Karnsombat P, Choubtum L, Sriphrapradang A, et al. Bone histomorphometry in children and adolescents with β-thalassemia disease: iron-associated focal osteomalacia. J Clin Endocrinol Metabolism. 2003 Aug 1;88(8):3966-72.

De Sanctis V, Vullo C, Bagni B, Chiccoli L. Hypoparathyroidism in b-thalassemia major. Clinical and laboratory observation in 24 patients. Acta Hematol. 1992;88(2-3):105-8.

Zafeiriou D, Athanasiou M, Katzos G, Economou M, Kontopoulos E. Hypoparathyroidism and intracranial calcification in β-thalassemia major. J Pediatr. 2001;138(3):411.

Karimi M, Habibzadeh F, De Sanctis V. Hypoparathyroidism with extensive intracranial calcification in patients with bthalassemia major. J Pediatr Endocrinol Metab 2003;16(6):883-6.

Aloia JF, Ostuni JA, Yeh JK, Zaino EC. Combined vitamin D parathyroid defect in thalassemia major. Arch Intern Med. 1982;142(4):831-2.

Vogiatzi MG, Macklin EA, Fung EB, Cheung AM, Vichinsky E, Olivieri N, et al. Thalassemia Clinical Research Network.Bone disease in thalassemia: A frequent and still unresolved problem. J Bone Miner Res 2009;24:543-57.

Soliman A, Adel A, Wagdy M, Al Ali M, ElMulla N. Calcium homeostasis in 40 adolescents with beta-thalassemia major: a case-control study of the effects of intramuscular injection of a megadose of cholecalciferol. Pediatr Endocrinol Rev. 2008;6(Suppl 1):149-54.

Chatterjee M. Vitamin D and genomic stability. Mutat Res. 2001;475:69-87.

Holick M. Vitamin D and sunlight: strategies for cancer prevention and other health benefits. Clin J Am Soc Nephrol. 2008;3:1548-54.

Dibble JB, Sheridan P, Hampshire R, Hardy GJ, Losowsky MS. Osteomalacia, vitamin D deficiency and cholestasis in chronic liver disease. Q J Med. 1982;51:89-103.

Chow LH, Frei JV, Hodsman AB, Valberg LS. Low serum 25-hydroxyvitamin D in hereditary hemochromatosis: relation to iron status. Gastroentrology. 1985;88(4):865-9.

Yassin M A, Soliman A T, Sanctis V, Abdula M, Riaz L, Ghori F et al. Statural Growth and Prevalence of Endocrinopathies in Relation to Liver Iron Content (LIC) in Adult Patients with Beta Thalassemia Major (BTM) and Sickle Cell Disease (SCD). Acta Biomed. 2018;89(2-S):33-40.

Vogiatzi MG, Macklin EA, Trachtenberg FL, Fung EB, Cheung AM, Vichinsky E, et al. Thalassemia Clinical Research Network. Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassemia syndromes in North America. Br J Haematol. 2009;146:546-56.

Shamshirsaz AA, Bekheirnia MR, Kamgar M, Pourzahedgilani N, Bouzari N, Habibzadeh M, et al. Metabolic and endocrinologic complications in beta-thalassaemia major: A multicenter study in Tehran. BMC Endocr Disord. 2003;3:4.

Napoli N, Carmina E, Bucchieri S, Sferrazza C, Rini GB, Di Fede G. Low serum levels of 25-hydroxy vitamin D in adults affected by thalassaemia major or intermedia. Bone. 2006;38:888-92.

Ezzat HM, Wu J, McCartney H, Leitch HA. Vitamin D Insufficiency and Liver Iron Concentration in Transfusion Dependent Hemoglobinopathies in British Columbia. Open J Hematol. 2015:6-6.

Lasco A, Morabito N, Gaudio A, Buemi M, Wasniewska M, Frisina N. Effects of hormonal replacement therapy on bone metabolism in young adults with beta thalassemia major. Osteoporos Int. 2001;12:570-5.

Pollak RD, Rachmilewita E, Blumenfeld A, Idelson M, Goldfarb AW. Bone mineral metabolism in adults with -thalassaemia major and intermedia. Br J Haematol. 2000;111(3):902-7.

Chow LH, Frei JV, Hodman AB, Valberg LS 1985 Low serum 25 hydroxyvitamin D in hereditary hemochromatosis. Relation to iron status. Gastroenterol. 88(4):865-9.

Domrongkitchaiporn S, Sirikulchayanontata V, Angchaisuksiri V, Stitichantrakul W, Kanokkantapong C, Rajatanavin R. Abnormalities in Bone Mineral Density and Bone Histology in Thalassemia. J Bone and Mineral Res. 2003;18(9):1682-8.

Rioja L, Girot R, Garabedian M, Cournot-Witmer G. Bone disease in children with homozygous beta-thalassaemia. Bone Miner. 1990;8(1):69-86.